Qutenza

DRUG12 trials

Sponsors

Astellas Pharma Inc, Imperial College London, Emma Aitken, Astellas Pharma Europe Ltd., NHS Greater Glasgow and Clyde

Conditions

Arteriovenous FistulaeCIPN - Chemotherapy-Induced Peripheral NeuropathyChemotherapy-induced Peripheral NeuropathyDuloxetineEnd Stage Renal FailureKnee OsteoarthritisLower Limb AmputationNeuralgia, Postherpetic

Phase 1

A Study to Compare Levels of Capsaicin After Intra-Articular Injection and Topical Application in Patients With Painful Knee Osteoarthritis

CompletedNCT03576508

Centrexion TherapeuticsKnee Osteoarthritis

Start: 2018-06-25End: 2018-09-06Updated: 2018-11-14

Phase 2

Qutenza®-Remodulin® in Pulmonary Arterial Hypertension Patients

CompletedNCT01393795

Imperial College LondonPain, Pulmonary Hypertension

Start: 2011-08-31End: 2012-07-31Updated: 2023-10-05

Clinical Trial Assessing the Efficacy of Capsaicin Patch (Qutenza®) in Cancer Patients With Neuropathic Pain

CompletedNCT03317613

Centre Hospitalier Universitaire de Saint EtienneNeuropathic Pain

Start: 2017-11-09End: 2021-12-20Updated: 2022-02-08

Phase 3

A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic Patients

CompletedNCT01478607

Astellas Pharma IncPainful Diabetic Peripheral Neuropathy (PDPN)

Start: 2011-11-30End: 2014-02-28Updated: 2015-10-14

Phase 4

Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve Damage

CompletedNCT01252160

Astellas Pharma IncNeuralgia, Postherpetic

Start: 2010-10-28End: 2013-09-26Updated: 2018-04-19

Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch

CompletedNCT01416116

Astellas Pharma Incor Peripheral Nerve Injury (PNI), Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN)

Start: 2011-07-06End: 2012-04-25Updated: 2018-04-23

Qutenza for Critical Ischaemia in End Stage Renal Failure

Emma AitkenEnd Stage Renal Failure, Neuropathic Pain

Start: 2012-12-31End: 2014-03-31Target: 20Updated: 2012-10-11

A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of Treatment

CompletedNCT01713426

Astellas Pharma Europe Ltd.Non-diabetic Painful Peripheral Polyneuropathy, Peripheral Nerve Injury (PNI), Postherpetic Neuralgia (PHN)

Start: 2012-07-11End: 2013-09-26Updated: 2018-04-23

Unknown Phase

Qutenza (Topical Capsaicin 8%) for Painful Arteriovenous Fistulae

NHS Greater Glasgow and ClydeArteriovenous Fistulae, Neuropathic Pain

Start: 2015-11-30End: 2017-08-31Target: 20Updated: 2016-11-11

Pre-emptive Analgesia With Qutenza in Lower Limb Amputation

NHS Greater Glasgow and ClydeLower Limb Amputation, Neuropathic Pain

Start: 2013-02-28End: 2014-05-31Target: 30Updated: 2012-12-12

A Study of Efficacy and Safety of Qutenza in Patients With Post-operative Peripheral Neuropathic Pain

CompletedNCT02171182

Astellas Pharma s.r.o.Post-operative Peripheral Neuropathic Pain

Start: 2014-01-31End: 2015-08-31Updated: 2016-02-08

Qutenza Versus Duloxetine in Chemotherapy-induced Peripheral Neuropathy (CIPN)

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Chemotherapy-induced Peripheral Neuropathy, CIPN - Chemotherapy-Induced Peripheral Neuropathy, Duloxetine +1

Start: 2022-12-01End: 2025-12-31Target: 102Updated: 2023-12-15

Related Papers

Treatment Impact on Patient-Reported Outcomes in Peripheral Neuropathic Pain: Comparing Single Intervention With Topical High-Concentration Capsaicin to Daily Oral Pregabalin

Pain Physician2021-09-1710 citations

Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study

BMC Neurology2016-12-01102 citations

Cost-Effectiveness of Capsaicin 8% Patch Compared with Pregabalin for the Treatment of Patients with Peripheral Neuropathic Pain in Scotland

PLoS ONE2016-03-1632 citations